CURRENT POSITION

Biomedical researcher at the Hospital Clínic de Barcelona.

ORGANISM

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). 

TITLES

• 2013: Ph.D. in Biochemistry by the Universitat de Barcelona.

• 2010: Manipulation of animal models.

• 2010: Master in Research in Liver Diseases by the Universitat de Barcelona.

• 2008: Degree in Biochemistry by the Universitat de Barcelona.

• 2006: Degree in Chemistry by the Universitat de Barcelona.

LANGUAGES

• Catalan and Spanish: native level

• English: Level 5 in EOI (Official School of Languages of Catalonia) (Equivalent to B2)

CAREER

My studies are focused on the liver and in different alterations in the organism during cirrhosis and chronic liver diseases, especially vascular dysfunction.

•        Speciality in Molecular Biology: protein and RNA extraction, Western Blot, immunocitochemistry, immunohistochemistry, immunofluorescence, immunoprecipitation, cellular migration and proliferation assays, conventional PCR and Real Time, flux cytometry, epifluorescence microscopy, electronic microscopy, ELISA, etc.

•        Proteomics: Mass spectrometry (SELDI-TOF).

•        Manipulation of mice and rats: administration of drugs, tissue and blood extraction, genotyping, surgery (partial hepatectomy, femoral ligation), tumour induction, etc.

•        Imaging techniques in vivo: angiography, linfangiography, etc.

•        Experience in cellular cultures, lines (BAEC, HepG2, HUVEC, LX2, HEK293, LLC1…) and isolation of primary cells (LSEC, LyECs, HSC, PVEC, Hepatocytes, …) with different techniques: density gradient, elutriation, magnetic staining, etc.

•        Professor in the Master of Biomedicine at the Universitat de Barcelona in the years 2010-2011, 2011-2012 and 2012-2013.

RESEARCH INTERESTS

-          EndMT (endothelial-to-mesenchymal transition).

-          Lymphatic dysfunction.

-          Angiogenesis.

-          Isolation of different kind of cells from control and cirrhotic rat livers, characterization and study of their phenotypic differences.

-          Nanotechnology and hepatic regeneration in mice.

-          Cancer, metastases and targets of AKT.